About Krista H Vandenborne
Dr. Krista Vandenborne’s research has focused on the implementation of magnetic resonance imaging (MRI) and spectroscopy (MRS) to characterize skeletal muscle in patients. Her laboratory has applied magnetic resonance to the study of skeletal muscle in numerous animal models and a variety of patient populations. Over the last ten years, she has been leading the efforts at the University of Florida to develop a strong translational research program dedicated to the development and validation of MR imaging biomarkers for muscular dystrophy. She serves as the current Director of this project, known as ImagingDMD, which is focused on the development and validation of MRI/MRS biomarkers in Duchenne Muscular Dystrophy. ImagingDMD has collected longitudinal MR images, functional data, clinical endpoints, demographics, and biosamples in ~180 patients with DMD, with 1-9 year followup. The comprehensive natural history data set acquired by ImagingDMD is viewed as one of the field’s most valuable resources for clinical trial design and is utilized by academia, industry and governmental organizations modeling disease trajectory.